(Q36798007)

16 August 2017

1 reference

title

Prevalence and determinants of transmitted antiretroviral drug resistance in HIV-1 infection (English)

1 reference

16 August 2017

0 references

anti-retroviral agent

0 references

1 reference

Clare L Booth

1

1 reference

16 August 2017

Anna Maria Geretti

series ordinal

2

1 reference

16 August 2017

language of work or name

English

0 references

publication date

19 April 2007

1 reference

Journal of Antimicrobial Chemotherapy

16 August 2017

number of pages

10

1 reference

based on heuristic

inferred from page(s)

published in

1 reference

16 August 2017

volume

59

1 reference

16 August 2017

issue

6

1 reference

16 August 2017

page(s)

1047-1056

1 reference

Brief report: primary infection with zidovudine-resistant human immunodeficiency virus type 1.

16 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKM082

HIV-1 drug resistance in newly infected individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKM082

Transmission of zidovudine-resistant human immunodeficiency virus type 1 variants following deliberate injection of blood from a patient with AIDS: characteristics and natural history of the virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKM082

Antiretroviral recommendations may influence the rate of transmission of drug-resistant HIV type 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKM082

Clinical utility of HIV standard genotyping among antiretroviral-naive individuals with unknown duration of infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKM082

The Calculated Genetic Barrier for Antiretroviral Drug Resistance Substitutions Is Largely Similar for Different HIV-1 Subtypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKM082

HIV-1 protease and reverse transcriptase mutations for drug resistance surveillance

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKM082

Genotypic and phenotypic analyses of human immunodeficiency virus type 1 in antiretroviral drug-naive Nigerian patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKM082

Short communication: low prevalence of genotypic drug resistance mutations among antiretroviral-naive HIV type 1 patients in Malaysia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKM082

Low prevalence of primary antiretroviral resistance mutations and predominance of HIV-1 clade C at polymerase gene in newly diagnosed individuals from south Brazil

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKM082

Linking HIV and Antiretroviral Drug Resistance Surveillance in Peru

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKM082

Prevalence of antiretroviral drug resistance mutations and HIV-1 non-B subtypes in newly diagnosed drug-naïve patients in Slovenia, 2000-2004.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKM082

HIV type 1 pol gene diversity and antiretroviral drug resistance mutations in the Democratic Republic of Congo (DRC).

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKM082

Trends in antiretroviral drug resistance and clade distributions among HIV-1--infected blood donors in Sao Paulo, Brazil

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKM082

Prevalence and predictors of antiretroviral drug resistance in newly diagnosed HIV-1 infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKM082

A population-based approach to determine the prevalence of transmitted drug-resistant HIV among recent versus established HIV infections: results from the Canadian HIV strain and drug resistance surveillance program

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKM082

Prevalence of resistance-associated mutations in newly diagnosed HIV-1 patients in Greece.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKM082

Prevalence of drug-resistant HIV-1 variants in untreated individuals in Europe: implications for clinical management

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKM082

Time trends in primary resistance to HIV drugs in the United Kingdom: multicentre observational study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKM082

Drug-resistance mutations in antiretroviral-naïve patients with established HIV-1 infection in Mexico.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKM082

Prevalence of primary HIV-1 drug resistance among recently infected adolescents: a multicenter adolescent medicine trials network for HIV/AIDS interventions study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKM082

Primary HIV drug resistance and efficacy of first-line antiretroviral therapy guided by resistance testing

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKM082

Epidemiology of antiretroviral drug resistance in drug-naïve persons

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKM082

Long-term persistence of primary genotypic resistance after HIV-1 seroconversion

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKM082

Stability of transmitted drug-resistant HIV-1 species

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKM082

Antiretroviral-drug resistance among patients recently infected with HIV.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKM082

Diversity of thymidine analogue resistance genotypes among newly diagnosed HIV-1-infected persons

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKM082

Transmitted human immunodeficiency virus type 1 carrying the D67N or K219Q/E mutation evolves rapidly to zidovudine resistance in vitro and shows a high replicative fitness in the presence of zidovudine

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKM082

Risk of failure in patients with 215 HIV-1 revertants starting their first thymidine analog-containing highly active antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKM082

Tracking the prevalence of transmitted antiretroviral drug-resistant HIV-1: a decade of experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKM082

Decline in the rate of genotypic resistance to antiretroviral drugs in recent HIV seroconverters in Madrid

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKM082

Acute HIV infection: impact on the spread of HIV and transmission of drug resistance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKM082

Prevalence of HIV-1 primary drug resistance in seroconverters of the ICoNA cohort over the period 1996-2001.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKM082

Carrier rate of zidovudine-resistant HIV-1: the impact of failing therapy on transmission of resistant strains.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKM082

Predicting the unpredictable: transmission of drug-resistant HIV.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKM082

A tale of two futures: HIV and antiretroviral therapy in San Francisco.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKM082

Time trends in primary HIV-1 drug resistance among recently infected persons

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKM082

Analysis of human immunodeficiency virus in semen: indications of a genetically distinct virus reservoir

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKM082

Differential virus evolution in blood and genital tract of HIV-infected females: evidence for the involvement of drug and non-drug resistance-associated mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKM082

Compartmentalization of HIV-1 between Breast Milk and Blood of HIV-Infected Mothers

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKM082

Implications of antiretroviral resistance on viral fitness

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKM082

Replicative fitness in vivo of HIV-1 variants with multiple drug resistance-associated mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKM082

Transmission fitness of drug-resistant human immunodeficiency virus and the prevalence of resistance in the antiretroviral-treated population

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKM082

Replication capacity, biological phenotype, and drug resistance of HIV strains isolated from patients failing antiretroviral therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKM082

Diminished representation of HIV-1 variants containing select drug resistance-conferring mutations in primary HIV-1 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKM082

Genetic basis of hypersusceptibility to protease inhibitors and low replicative capacity of human immunodeficiency virus type 1 strains in primary infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKM082

Persistence and fitness of multidrug-resistant human immunodeficiency virus type 1 acquired in primary infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKM082

Persistence of primary drug resistance among recently HIV-1 infected adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKM082

HIV-1 resistant strains acquired at the time of primary infection massively fuel the cellular reservoir and persist for lengthy periods of time

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKM082

Progressive reversion of human immunodeficiency virus type 1 resistance mutations in vivo after transmission of a multiply drug-resistant virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKM082

The impact of transmitted drug resistance on the natural history of HIV infection and response to first-line therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKM082

Detection of minor populations of drug-resistant HIV-1 in acute seroconverters.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKM082

Selection and persistence of non-nucleoside reverse transcriptase inhibitor-resistant HIV-1 in patients starting and stopping non-nucleoside therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKM082

British HIV Association (BHIVA) guidelines for the treatment of HIV-infected adults with antiretroviral therapy (2006).

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKM082

Antiretroviral drug resistance testing in adults infected with human immunodeficiency virus type 1: 2003 recommendations of an International AIDS Society-USA Panel

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKM082

HIV drug resistance acquired through superinfection

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKM082

Incidence of HIV superinfection following primary infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKM082

Persistence of multidrug-resistant HIV-1 in primary infection leading to superinfection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKM082

Clade B HIV-1 superinfection with wild-type virus after primary infection with drug-resistant clade B virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKM082

Trends in drug resistance mutations in antiretroviral-naïve intravenous drug users of Rio de Janeiro

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKM082

Do patients who are infected with drug-resistant HIV have a different CD4 cell decline after seroconversion? An exploratory analysis in the UK Register of HIV Seroconverters

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKM082

21 January 2018

Identifiers

DOI

10.1093/JAC/DKM082

1 reference

release_ds7vemvvcjecbastajvtbtczsi

16 August 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/ds7vemvvcjecbastajvtbtczsi

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference